Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/07/21
Covid vaccine makers' shares seesaw after Biden administration says it will back patent waiversCNBC • 05/06/21
Vaccine Stocks Pare Deep Losses As Angela Merkel Opposes Waiving PatentsInvestors Business Daily • 05/06/21
Moderna's first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposalMarket Watch • 05/06/21
Will Moderna (MRNA) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 05/06/21
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine PlayBenzinga • 05/06/21
Moderna, Pfizer drop after US backs proposal to lift patent protection for COVID-19 vaccines to boost supplyProactive Investors • 05/06/21
Moderna Says Covid-19 Vaccine Is 96% Effective In Teenagers, Will File For Full FDA ApprovalForbes • 05/06/21